IL133907D0 - Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor - Google Patents

Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor

Info

Publication number
IL133907D0
IL133907D0 IL13390798A IL13390798A IL133907D0 IL 133907 D0 IL133907 D0 IL 133907D0 IL 13390798 A IL13390798 A IL 13390798A IL 13390798 A IL13390798 A IL 13390798A IL 133907 D0 IL133907 D0 IL 133907D0
Authority
IL
Israel
Prior art keywords
glucocidase
thiazolidinedione
diabetes
inhibitor
alpha
Prior art date
Application number
IL13390798A
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB9715298A priority Critical patent/GB9715298D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Priority to PCT/GB1998/002112 priority patent/WO1999003478A1/en
Publication of IL133907D0 publication Critical patent/IL133907D0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
IL13390798A 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor IL133907D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB9715298A GB9715298D0 (en) 1997-07-18 1997-07-18 Novel method of treatment
PCT/GB1998/002112 WO1999003478A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor

Publications (1)

Publication Number Publication Date
IL133907D0 true IL133907D0 (en) 2001-04-30

Family

ID=10816170

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13390798A IL133907D0 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor

Country Status (27)

Country Link
EP (1) EP1001784A1 (en)
JP (1) JP2001510160A (en)
KR (1) KR20010021952A (en)
CN (1) CN1263467A (en)
AP (1) AP200001735A0 (en)
AR (2) AR016350A1 (en)
AU (1) AU8449098A (en)
BG (1) BG104062A (en)
BR (1) BR9810292A (en)
CA (1) CA2297133A1 (en)
CO (1) CO4940489A1 (en)
DZ (1) DZ2563A1 (en)
EA (1) EA200000140A1 (en)
GB (1) GB9715298D0 (en)
HU (1) HU0003626A3 (en)
ID (1) ID23804A (en)
IL (1) IL133907D0 (en)
MA (1) MA24608A1 (en)
NO (1) NO20000230D0 (en)
OA (1) OA11312A (en)
PE (1) PE99499A1 (en)
PL (1) PL338140A1 (en)
SK (1) SK612000A3 (en)
TR (1) TR200000133T2 (en)
UY (1) UY25101A1 (en)
WO (1) WO1999003478A1 (en)
ZA (1) ZA9806364B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
ES2291210T3 (en) * 1999-06-21 2008-03-01 Eli Lilly And Company thiazolidinediones synergistic with glucagon peptide-1 type and its agonists for treating insulin-dependent diabetes not.
CA2673615C (en) * 2000-01-21 2013-07-16 Novartis Ag Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents
JP4917712B2 (en) * 2000-02-24 2012-04-18 武田薬品工業株式会社 Pharmaceutical combination
EP1295609A4 (en) * 2000-02-24 2004-11-03 Takeda Chemical Industries Ltd Drugs containing combined active ingredients
US7964216B2 (en) 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
FR2832930A1 (en) * 2001-12-03 2003-06-06 Lipha Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a thiazolidinedione derivative and use thereof for the preparation of medicaments for the treatment of diabetes
KR20100012105A (en) 2003-10-31 2010-02-05 다케다 야쿠힌 고교 가부시키가이샤 Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
CN101103993B (en) 2006-07-14 2011-03-30 北京华安佛医药研究中心有限公司 Hypoglycemic medicine composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2101866T3 (en) * 1991-08-26 1997-07-16 Upjohn Co liquid food product containing 3-guanidinopropionic.
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
AR019724A2 (en) 2002-03-13
PL338140A1 (en) 2000-09-25
MA24608A1 (en) 1999-04-01
CO4940489A1 (en) 2000-07-24
ID23804A (en) 2000-05-11
HU0003626A2 (en) 2001-05-28
GB9715298D0 (en) 1997-09-24
EA200000140A1 (en) 2000-06-26
EP1001784A1 (en) 2000-05-24
JP2001510160A (en) 2001-07-31
OA11312A (en) 2003-10-24
TR200000133T2 (en) 2000-09-21
NO20000230D0 (en) 2000-01-17
HU0003626A3 (en) 2001-12-28
AU8449098A (en) 1999-02-10
PE99499A1 (en) 1999-12-18
NO20000230L (en) 2000-01-17
DZ2563A1 (en) 2003-02-15
AR016350A1 (en) 2001-07-04
BG104062A (en) 2000-11-30
BR9810292A (en) 2000-09-19
WO1999003478A1 (en) 1999-01-28
CA2297133A1 (en) 1999-01-28
ZA9806364B (en) 2000-01-17
AP200001735A0 (en) 2000-03-31
CN1263467A (en) 2000-08-16
UY25101A1 (en) 2000-12-29
SK612000A3 (en) 2000-07-11
KR20010021952A (en) 2001-03-15

Similar Documents

Publication Publication Date Title
AU639456B2 (en) Diagnosis and treatment of insulin dependent diabetes mellitus
AU680669B2 (en) Medical treatment using thyroid hormones
AU775063C (en) Modified exendins and exendin agonists
PT885961E (en) New insulin derivatives with quick start start
HK1040910A1 (en) Pharmaceutical composition for modified release of an insulin sensitiser and metformin
MXPA01012435A (en) Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia.
HU0103714A3 (en) Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity, medicaments containing them and their use
IL115583D0 (en) Glucagon-like insulinotropic peptide analogs, compositions, and method of use
HRP20040814A2 (en) Aryl 5-thio-?-d-glucopyranoside derivatives and therapeutic agents for diabetes containing the same
GB9721437D0 (en) Heteroaromatic compounds and their use in medicine
NZ514095A (en) Amide compounds and medicinal use thereof
MXPA03003870A (en) Combination therapy comprising anti-diabetic and anticonvulsant agents.
IL136377D0 (en) Glucagon-like peptide-1 crystals
NZ250844A (en) Treatment of non-insulin dependant diabetes with peptides; composition
PT989131E (en) Compounds of trienotriazolodiazepina and its uses for medical purposes
AU2002244860A1 (en) Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase IV
PL192364B1 (en) Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
PL374934A1 (en) Peptides and related compounds having thrombopoietic activity
IL185763A (en) Peptide conjugate comprising glp-1 and uses thereof
ZA200105165B (en) Treatment and prevention of reactive oxygen metabolite-mediated cellular damage.
AU2003241173A8 (en) 1,2-azole derivatives with hypoglycemic and hypolipidemic activity
HU9501922D0 (en) Extended release, film-coated tablet of astemizole and pseudoephedrine
IL133431A (en) Device for treatment of dysmenorrhea and its use
HU9903405A3 (en) Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids with metalloproteinase inhibitor activity, preparation and use thereof
RU93043625A (en) Composition including tramadol and acetaminophen substance, and method of treatment with its use